In8bio Free Cash Flow (FCF) History (INAB)

In8bio reported −$24.3M in free cash flow for fiscal 2024, a decrease of $396,000 from the previous fiscal year.

View full In8bio company overview

In8bio free cash flow by year

In8bio annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$24.3M−$396,000
20232023-12-31−$23.9M$3.9M
20222022-12-31−$27.8M−$14.0M
20212021-12-31−$13.8M

In8bio free cash flow growth trends

In8bio's latest reported quarter, Q2 2026, generated −$4.0M in free cash flow, a decrease of $51,000 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review In8bio source filings ↗

Community posts

It’s quiet here.

No posts about INAB yet. Start the conversation.

Write the first post